Douglas B. Flieder

19.3k total citations · 3 hit papers
86 papers, 5.2k citations indexed

About

Douglas B. Flieder is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Douglas B. Flieder has authored 86 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 19 papers in Surgery. Recurrent topics in Douglas B. Flieder's work include Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (18 papers) and Medical Imaging and Pathology Studies (13 papers). Douglas B. Flieder is often cited by papers focused on Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (18 papers) and Medical Imaging and Pathology Studies (13 papers). Douglas B. Flieder collaborates with scholars based in United States, Netherlands and Japan. Douglas B. Flieder's co-authors include William D. Travis, Michael N. Koss, Marian V. Fleming, Anthony A. Gal, Roni T. Falk, Walter L. Rush, John A. Ridge, Ranee Mehra, Thomas J. Galloway and César A. Moran and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Douglas B. Flieder

83 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival Analysis of 200 Pulmonary Neuroendocrine Tumors With Clarification of Criteria for Atypical Carcinoid and Its Separation From Typical Carcinoid

1998 594 citations William D. Travis, Walter L. Rush et al. The American Journal of Surgical Pathology profile →
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

2017 576 citations David L. Rimm, Gang Han et al. profile →
Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

2015 298 citations Elizabeth A. Handorf, Brian L. Egleston et al. profile →

Peers

Countries citing papers authored by Douglas B. Flieder

Since Specialization

Citations

This map shows the geographic impact of Douglas B. Flieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Flieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Flieder more than expected).

Fields of papers citing papers by Douglas B. Flieder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas B. Flieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Flieder. The network helps show where Douglas B. Flieder may publish in the future.

Co-authorship network of co-authors of Douglas B. Flieder

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Flieder. A scholar is included among the top collaborators of Douglas B. Flieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Flieder. Douglas B. Flieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma 2024 ·Cancer Research Communications ·(unknown), (unknown), Antonia Boyer, Xiao Lei Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Douglas B. Flieder, Denise C. Connolly, Alfredo Molinolo, Michael McHale, Dwayne G. Stupack, David D. Schlaepfer	1
2	SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) 2023 ·Clinical Cancer Research ·Sujana Movva, (unknown), Elizabeth A. Handorf, Edwin Choy, Priscilla Merriam, Douglas B. Flieder, Kathy Q. Cai, Yan Zhou, Eric D. Tetzlaff, (unknown), Emma Barker, (unknown), (unknown), Lori Rink, Margaret von Mehren, Suzanne George	14
3	Loss of Pkd1 limits susceptibility to colitis and colorectal cancer 2023 ·Oncogenesis ·Anna S. Nikonova, Alexander Y. Deneka, (unknown), (unknown), Rossella Tricarico, Anna A. Kiseleva, Yan Zhou, Émmanuelle Nicolas, Douglas B. Flieder, Sergei I. Grivennikov, Erica A. Golemis	3
4	Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer 2021 ·Cancer Research ·Alexander Y. Deneka, Meghan C. Kopp, Anna S. Nikonova, (unknown), Anna A. Kiseleva, Harvey H. Hensley, Douglas B. Flieder, Ilya G. Serebriiskii, Erica A. Golemis	13
5	Prospective randomized trial to compare the safety, diagnostic yield and utility of 22-gauge and 19-gauge endobronchial ultrasound transbronchial needle aspirates and processing technique by cytology and histopathology 2021 ·Journal of the American Society of Cytopathology ·Christopher Manley, Rohit Kumar, Yulan Gong, (unknown), Shuanzeng Wei, (unknown), (unknown), Brian L. Egleston, Douglas B. Flieder, Hormoz Ehya	12
6	Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors 2021 ·Applied immunohistochemistry & molecular morphology ·Jianming Pei, Douglas B. Flieder, Jacqueline Talarchek, Harry S. Cooper, Arthur S. Patchefsky, Shuanzeng Wei	4
7	Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing 2019 ·Modern Pathology ·Jianming Pei, Douglas B. Flieder, Arthur S. Patchefsky, Jacqueline Talarchek, Harry S. Cooper, Joseph R. Testa, Shuanzeng Wei	30
8	P3.01-009 A Prospective Study of ‘Spread through a Knife Surface' (STAKS) in Non-Small Cell Lung Cancer Resection Specimens 2017 ·Journal of Thoracic Oncology ·Hans Blaauwgeers, Douglas B. Flieder, Arne Warth, Kim Monkhorst, (unknown), Birgit I. Lissenberg‐Witte, Erik Thunnissen	3
9	ORAL01.01: A Prospective, Multi-Institutional Assessment of Four Assays for PD-L1 Expression in NSCLC by Immunohistochemistry 2016 ·Journal of Thoracic Oncology ·David L. Rimm, Gang Han, Janis M. Taube, Eunhee S. Yi, Julia A. Bridge, Douglas B. Flieder, Robert Homer, William W. West, Hong Wu, Anja C. Roden, Junya Fujimoto, Hui Yu, Robert A. Anders, Ashley Kowalewski, Christopher J. Rivard, Jamaal Rehman, Fred R. Hirsch, Ignacio I. Wistuba	8
10	Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015 ·Cambridge University Press eBooks ·Mark R. Wick, (unknown), Edward C. Klatt, Tarik M. Elsheikh, Kenneth B. Calder, Elizabeth A. Montgomery, John D. Pfeifer, Karen Chang, Nian X. Sun, Michael J. Klein, Yaxia Zhang, Edward B. Stelow, James S. Lewis, Anja C. Roden, Douglas B. Flieder, Elizabeth N. Pavlisko, Allen Burke, Robert O. Greer, Raja R. Seethala	7
11	Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers 2013 ·Clinical Cancer Research ·Ranee Mehra, Fang Zhu, Dong‐Hua Yang, Kathy Q. Cai, JoEllen Weaver, Mahendra Singh, Anna S. Nikonova, Erica A. Golemis, Douglas B. Flieder, Harry S. Cooper, Miriam N. Lango, John A. Ridge, Barbara Burtness	21
12	Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors 2008 ·Proceedings of the National Academy of Sciences ·Chi Tarn, Lori Rink, Erin Merkel, Douglas B. Flieder, Harsh B. Pathak, (unknown), Joseph R. Testa, Burton Eisenberg, Margaret von Mehren, Andrew K. Godwin	197
13	Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening 2007 ·Lung Cancer ·Darryl Carter, Madeline Vazquez, Douglas B. Flieder, E. Brambilla, Adi F. Gazdar, Masayuki Noguchi, William D. Travis, (unknown), Rowena Yip, David F. Yankelevitz, Claudia I. Henschke	72
14	Benign Thymic Hyperplasia As a Cause of Anterior Mediastinal Mass After Chemotherapy 2004 ·CHEST Journal ·Douglas B. Flieder, (unknown), Abraham Sanders, (unknown)	0
15	Primary paraganglioma of the lung 2004 ·Annals of Diagnostic Pathology ·(unknown), Douglas B. Flieder	21
16	Nonspecific interstitial pneumonia: a provisional category of idiopathic interstitial pneumonia 2004 ·Current Opinion in Pulmonary Medicine ·Douglas B. Flieder, Michael N. Koss	3
17	Bronchoalveolar carcinoma: Clinical, radiologic, and pathologic factors and survival 1999 ·Journal of Thoracic and Cardiovascular Surgery ·K. Okubo, Eugene J. Mark, Douglas B. Flieder, John C. Wain, Cameron D. Wright, Ashby C. Moncure, (unknown), Douglas J. Mathisen	74
18	Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women 1999 ·JNCI Journal of the National Cancer Institute ·William P. Bennett, Michael C.R. Alavanja, Brunhilde Blömeke, Kirsi Vähäkangas, Katariina Castrén, Judith A. Welsh, Elise D. Bowman, Khan Ma, Douglas B. Flieder, Curtis C. Harris	143
19	Survival Analysis of 200 Pulmonary Neuroendocrine Tumors With Clarification of Criteria for Atypical Carcinoid and Its Separation From Typical Carcinoid breakdown → 1998 ·The American Journal of Surgical Pathology ·William D. Travis, Walter L. Rush, Douglas B. Flieder, Roni T. Falk, Marian V. Fleming, Anthony A. Gal, Michael N. Koss	594
20	Solitary Pulmonary Papillomas in Adults 1998 ·The American Journal of Surgical Pathology ·Douglas B. Flieder, Michael N. Koss, Andrew Nicholson, Isabell A. Sesterhenn, Robert E. Petras, William D. Travis	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact